PURPOSE: There is a compelling clinical imperative to identify discerning molecular biomarkers of hepatic disease in order to inform the diagnosis, prognosis and treatment. EXPERIMENTAL DESIGN: We have investigated the proteome of urinary vesicles present in urine samples obtained from experimental models for the study of liver injury, as an approach for identifying potential biomarkers for hepatic disease. RESULTS: The biochemical and proteomic characterization of highly purified exosome-like urinary vesicles has identified 28 proteins previously unreported in these vesicles, and many that have been previously associated with diseases, such as the prion-related protein. Furthermore, in urine samples from D-galactosamine-treated rats, a well-characterized experimental model for acute liver injury, we have detected a severe reduction in some proteins that normally are clearly detected in urinary vesicles. Finally, differential protein content on urinary vesicles from a mouse model for chronic liver injury has been also identified. CONCLUSIONS AND CLINICAL RELEVANCE: Our results argue positively that urinary vesicles could be a source for identifying non-invasive biomarkers of liver injury. We proposed some proteins such as Cd26, Cd81, Slc3A1 and Cd10 that have been found to be differentially expressed in urinary vesicles from some of the analyzed models as potential biomarkers for liver injury.
PURPOSE: There is a compelling clinical imperative to identify discerning molecular biomarkers of hepatic disease in order to inform the diagnosis, prognosis and treatment. EXPERIMENTAL DESIGN: We have investigated the proteome of urinary vesicles present in urine samples obtained from experimental models for the study of liver injury, as an approach for identifying potential biomarkers for hepatic disease. RESULTS: The biochemical and proteomic characterization of highly purified exosome-like urinary vesicles has identified 28 proteins previously unreported in these vesicles, and many that have been previously associated with diseases, such as the prion-related protein. Furthermore, in urine samples from D-galactosamine-treated rats, a well-characterized experimental model for acute liver injury, we have detected a severe reduction in some proteins that normally are clearly detected in urinary vesicles. Finally, differential protein content on urinary vesicles from a mouse model for chronic liver injury has been also identified. CONCLUSIONS AND CLINICAL RELEVANCE: Our results argue positively that urinary vesicles could be a source for identifying non-invasive biomarkers of liver injury. We proposed some proteins such as Cd26, Cd81, Slc3A1 and Cd10 that have been found to be differentially expressed in urinary vesicles from some of the analyzed models as potential biomarkers for liver injury.
Authors: Patricia A Gonzales; Trairak Pisitkun; Jason D Hoffert; Dmitry Tchapyjnikov; Robert A Star; Robert Kleta; Nam Sun Wang; Mark A Knepper Journal: J Am Soc Nephrol Date: 2008-12-03 Impact factor: 10.121
Authors: Laura J Vella; Deanne L V Greenwood; Roberto Cappai; Jean-Pierre Y Scheerlinck; Andrew F Hill Journal: Vet Immunol Immunopathol Date: 2008-04-16 Impact factor: 2.046
Authors: M Luz Martínez-Chantar; Mercedes Vázquez-Chantada; Usue Ariz; Nuria Martínez; Marta Varela; Zigmund Luka; Antonieta Capdevila; Juan Rodríguez; Ana M Aransay; Rune Matthiesen; Heping Yang; Diego F Calvisi; Manel Esteller; Mario Fraga; Shelly C Lu; Conrad Wagner; José M Mato Journal: Hepatology Date: 2008-04 Impact factor: 17.425
Authors: Kathryn A Patras; Albert D Ha; Emma Rooholfada; Joshua Olson; Satish P Ramachandra Rao; Ann E Lin; Victor Nizet Journal: J Innate Immun Date: 2019-05-03 Impact factor: 7.349
Authors: Joao A Paulo; Vivek Kadiyala; Aleksandr Gaun; John F K Sauld; Ali Ghoulidi; Peter A Banks; Hanno Steen; Darwin L Conwell Journal: JOP Date: 2013-03-10